oa SA Pharmaceutical Journal - New drug focus : drug info
|Article Title||New drug focus : drug info|
|© Publisher:||Medpharm Publications|
|Journal||SA Pharmaceutical Journal|
|Publication Date||Oct 2008|
Oxybutynin has been well-established as an effective treatment option for symptoms of OAB. The advantages of the OROS® formulation of oxybutynin over the immediate-release formulation are its ease of use due to once daily administration and an improved tolerability profile.
Article metrics loading...